Literature DB >> 2340853

Removal of famotidine by haemodialysis in elderly anuric patients.

N Inotsume1, M Nishimura, M Nakano, S Fujiyama, K Sagara, T Sato, K Matsushita, Y Imai, H Matsui.   

Abstract

The effect of haemodialysis on the pharmacokinetics of oral famotidine has been studied in five elderly anuric patients. Famotidine 20 mg was administered in a cross-over design to patients on and not on haemodialysis. The elimination rate constant of haemodialysis (k) was 4.6-fold larger than the systemic elimination rate constant (ke). Although the mean maximum serum concentration of famotidine during haemodialysis (141.5 ng.ml-1) was not significantly lower than that without haemodialysis (195.6 ng.ml-1), the AUC up to 5 h during haemodialysis was significantly decreased to 58.1% of the value without it. The data suggest that famotidine is dialysable by haemodialysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340853     DOI: 10.1007/bf00315039

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  4 in total

1.  Pharmacokinetics of famotidine in elderly patients with and without renal insufficiency and in healthy young volunteers.

Authors:  N Inotsume; M Nishimura; S Fujiyama; K Sagara; T Sato; Y Imai; H Matsui; M Nakano
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Hemodialysis clearance of cimetidine.

Authors:  N D Vaziri; R L Ness; C H Barton
Journal:  Arch Intern Med       Date:  1978-11

3.  Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis.

Authors:  R Larsson; P Erlanson; G Bodemar; B Norlander; L Fransson; L Strouth
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Removal of cimetidine by peritoneal dialysis, hemodialysis, and charcoal hemoperfusion.

Authors:  K M Pizzella; M C Moore; R W Schultz; J Walshe; J J Schentag
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

  4 in total
  2 in total

Review 1.  Pharmacokinetics and pharmacodynamics of H2-receptor antagonists in patients with renal insufficiency.

Authors:  U Gladziwa; U Klotz
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 2.  Pharmacokinetic optimisation of the treatment of peptic ulcer in patients with renal failure.

Authors:  U Gladziwa; U Koltz
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.